SCM
GH icon

Stevens Capital Management’s Guardant Health GH Stock Holding History

Stevens Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,721
Closed -$493K – 678
2019
Q3 		$493K Buy
+7,721
New +$680K 0.04% 356

Other funds holding GH

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Stevens Capital Management's GH Position: Q4 2019 in Review

Stevens Capital Management sold out of Guardant Health (GH) in Q4 2019, closing a stake of 7,721 shares — an estimated $493K sold.

Stevens Capital Management first reported a position in GH in Q3 2019 and held it in 1 quarter. The position peaked at $493K in Q3 2019. 268 funds tracked by Wall St. Rank hold GH as of Q4 2019.

  • Stevens Capital Management reported no remaining Guardant Health position as of Q4 2019 after selling out during the quarter.
  • Stevens Capital Management sold 7,721 Guardant Health shares in Q4 2019, an estimated $493K.
  • Stevens Capital Management first reported a position in Guardant Health in Q3 2019 and held it in 1 quarter.
  • Stevens Capital Management's Guardant Health position peaked at $493K in Q3 2019.
  • 268 funds tracked by Wall St. Rank held Guardant Health as of Q4 2019.

Based on Stevens Capital Management's 13F filing for Q4 2019, filed 6 Feb 2020.